miRagen Therapeutics Finds $20M
Boulder-based miRagen Therapeutics, which is developing biopharamceuticals for treating cardiovascular and muscle disease, said Tuesday that it has raised $20M in a Series B funding round. The round was led by Remeditex Ventures, and also included Atlas Venture, Boulder Ventures Ltd., Amgen Ventures, and Broadview Ventures. miRagen, whic his headed by William S. Marshall, said the funding will go towards development of its pipeline.
posted on Tuesday, April 24, 2012 (Link to more information)
Related companies:
Miragen Therapeutics
Related stories:
> miRagen Therapeutics Raises $40M, Goes Public In Reverse Merger
> miRagen Therapeutics In Strategic, Funding Deal With Servier
> Miragen Therapeutics Gains $3.0M More
> Miragen Therapeutics Raises $8M
> miRagen Therapeutics Gets $4M
Techrockies.com Home